Supplementation with a pine bark extract rich in polyphenols increases plasma antioxidant capacity and alters the plasma lipoprotein profile
Pycnogenol® (PYC), an extract of French maritime pine bark (Pinus pinaster), is a potent antioxidant with potential health benefits. Its bioavailabilty has previously been shown by urinary excretion studies of constituents and metabolites of PYC. The aim of this study was to test the effect of PYC supplementation on measures of oxidative stress and the lipid profile in humans. Twenty-five healthy subjects received PYC (150 mg/d) for 6 wk. Fasting blood was collected at baseline, after 3 and 6 wk of supplementation, and again after a 4-wk washout period. After 6 wk of supplementation with PYC, a significant increase in plasma polyphenol levels was detectable, which was reversed after the 4-wk washout phase. The antioxidant effect of PYC was demonstrated by a significant increase in oxygen radical absorbance capacity (ORAC) in plasma throughout the supplementation period (P<0.05). The ORAC value returned to baseline after the 4-wk washout period. Moreover, in addition to its antioxidant effects, PYC significantly reduced LDL-cholesterol levels and increased HDL-cholesterol levels in plasma of two-thirds of the subjects. While the LDL changes reversed during washout, the HDL increase did not. There was no significant difference in LDL oxidizability or plasma lipid peroxides following PYC supplementation. Hence, following oral supplementation in humans, PYC significantly increases antioxidant capacity of plasma, as determined by ORAC, and exerts favorable effects on the lipid profile.
KeywordsOxygen Radical Absorbance Capacity Taxifolin Dark Chocolate Chronic Venous Insufficiency Plasma Lipid Peroxide
body mass index
coronary artery disease
complete blood count
ferrous oxide-xylenol orange
oxygen radical absorbance capacity
reactive oxygen species
Unable to display preview. Download preview PDF.
- 11.Rohdewald, P. (1998) Pycnogenol®, in Flavonoids in Health and Disease (Rice-Evans, C.A., and Packer, L., eds., pp. 405–419, Marcel Dekker, New York.Google Scholar
- 14.Wang, S., Tan, D., Zhao, Y., Gao, G., Gao, X., and Hu, L., (1999) The Effect of Pycnogenol® on the Microcirculation, Platelet Function and Ischemic Myocardium in Patients with Coronary Artery Diseases, Eur. Bull. Drug Res. 7, 19–25.Google Scholar
- 15.Saliou, C., Rimbach, G., Moini, H., McLaughlin, L., Hosseini, S., Lee, J., Watson, R.R., and Packer, L. (2001) Solar Ultraviolet-Induced Erythema in Human Skin and Nuclear Factor-κB-Dependent Gene Express in Keratinocytes Are Modulated by a French Maritine Pine Bark Extract, Free Radic. Biol. Med. 30, 154–160.PubMedCrossRefGoogle Scholar
- 18.Grosse Düweler, K., and Rohdewald, P. (2000) Urinary Metabolites of French Maritine Pine Bark Extract in Humans, Pharmazie 55, 364–368.Google Scholar
- 27.Koch, R. (2002) Comparative Study of Venostasin and Pycnogenol in Chronic Venous Insufficiency, Phytother. Res. 16 (Suppl.), 2243–2250.Google Scholar
- 29.Fuhrman, B., Volkova, N., Kaplan, M., Presser, D., Attias, J., Hayek, T., and Aviram, M. (2002) Antiatherosclerotic Effects of Licorice Extract Supplmentation on Hypercholesterolemic Patients: Increased Resistance of LDL to Atherogenic Modifications, Reduced Plasma Lipid Levels, and Decreased Systolic Blood Pressure, Nutrition 18, 268–273.PubMedCrossRefGoogle Scholar